|
WO03103638A1
|
|
Stabilized pharmaceutical compositions containing benzimidazole compounds
|
|
AU2003237305A1
|
|
Process of preparation of olanzapine form i
|
|
US6693211B2
|
|
Chemical process
|
|
WO03042193A1
|
|
Process for preparing 5-methylisoxazole-4-carboxylic-(4'-trifluoromethyl)-anilide
|
|
EP1443911A1
|
|
Process for preparing quick dissolving, high loading ribavirin compositions
|
|
WO03004009A1
|
|
Pharmaceutical composition
|
|
AU2002248268A1
|
|
Crystal modification of olanzapine
|
|
US6740753B2
|
|
Olanzapine crystal modification
|
|
AU9690801A
|
|
Proton pump inhibitor formulation
|
|
US6631650B1
|
|
Thief sampling probe
|
|
US6458957B1
|
|
α,α-dibromo-α-chloro-acetophenones as synthons
|
|
US6613906B1
|
|
Crystal modification
|
|
US6201153B1
|
|
Synthesis of midodrine HCI from a novel intermediate 1-(2′,5′-dimethoxyphenyl)-2-azidoethanone
|
